A detailed history of Fmr LLC transactions in Galapagos Nv stock. As of the latest transaction made, Fmr LLC holds 2,887,831 shares of GLPG stock, worth $79.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,887,831
Previous 4,174,517 30.82%
Holding current value
$79.3 Million
Previous $134 Million 46.76%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$24.78 - $32.48 $31.9 Million - $41.8 Million
-1,286,686 Reduced 30.82%
2,887,831 $71.6 Million
Q1 2024

May 13, 2024

SELL
$32.2 - $42.44 $1.91 Million - $2.52 Million
-59,286 Reduced 1.4%
4,174,517 $134 Million
Q4 2023

Feb 13, 2024

SELL
$31.87 - $40.71 $2.67 Million - $3.41 Million
-83,873 Reduced 1.94%
4,233,803 $172 Million
Q3 2023

Nov 13, 2023

BUY
$34.17 - $42.98 $973,742 - $1.22 Million
28,497 Added 0.66%
4,317,676 $149 Million
Q2 2023

Aug 11, 2023

BUY
$37.4 - $44.52 $12.8 Million - $15.3 Million
342,646 Added 8.68%
4,289,179 $174 Million
Q1 2023

May 11, 2023

BUY
$36.5 - $48.0 $1.83 Million - $2.41 Million
50,156 Added 1.29%
3,946,533 $152 Million
Q4 2022

Feb 13, 2023

BUY
$37.44 - $46.51 $6.62 Million - $8.22 Million
176,789 Added 4.75%
3,896,377 $173 Million
Q3 2022

Nov 10, 2022

BUY
$42.27 - $57.6 $6.38 Million - $8.69 Million
150,938 Added 4.23%
3,719,588 $159 Million
Q2 2022

Aug 12, 2022

BUY
$52.3 - $71.59 $73.3 Million - $100 Million
1,401,691 Added 64.68%
3,568,650 $199 Million
Q1 2022

May 13, 2022

BUY
$51.32 - $68.5 $109 Million - $145 Million
2,117,458 Added 4277.61%
2,166,959 $134 Million
Q4 2021

Feb 14, 2022

SELL
$47.03 - $57.12 $1.77 Million - $2.16 Million
-37,739 Reduced 43.26%
49,501 $2.73 Million
Q3 2021

Nov 15, 2021

SELL
$52.17 - $70.2 $27 Million - $36.3 Million
-517,259 Reduced 85.57%
87,240 $4.59 Million
Q2 2021

Aug 13, 2021

BUY
$68.86 - $83.34 $41.6 Million - $50.4 Million
604,499 New
604,499 $41.6 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.81B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.